Cambrooke Therapeutics
About Cambrooke Therapeutics
Cambrooke Therapeutics is a company based in Boston (United States) founded in 2000 was acquired by Ajinomoto Health & Nutrition North America in November 2017.. Cambrooke Therapeutics has raised $17.28 million across 5 funding rounds from investors including Seventure Partners, Galen Partners and Ajinomoto Health & Nutrition North America. Cambrooke Therapeutics has completed 1 acquisition, including Nualtra. Cambrooke Therapeutics offers products and services including Glytactin and KetoVie.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ajinomoto Cambrooke, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.28 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Seventure Partners
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Ajinomoto Health & Nutrition North America
(Nov 09, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cambrooke Therapeutics
Cambrooke Therapeutics offers a comprehensive portfolio of products and services, including Glytactin and KetoVie. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Glytactin is utilized for managing PKU and other metabolic conditions, as it is designed to provide essential nutrients without increasing protein intake.
KetoVie is employed in ketogenic diets for epilepsy and related disorders, as it is formulated to simplify daily nutritional management.
Unlock access to complete
Funding Insights of Cambrooke Therapeutics
Cambrooke Therapeutics has successfully raised a total of $17.28M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(11 Jun 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2016 | Amount | Series C - Cambrooke Therapeutics | Valuation |
investors |
|
| Jan, 2016 | Amount | Unspecified - Cambrooke Therapeutics | Valuation |
investors |
|
| Jan, 2013 | Amount | Grant - Cambrooke Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cambrooke Therapeutics
Cambrooke Therapeutics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Seventure Partners, Galen Partners and Ajinomoto Health & Nutrition North America. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cambrooke Therapeutics
Cambrooke Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nualtra. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proprietary medical nutrition products are manufactured and marketed.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cambrooke Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cambrooke Therapeutics Comparisons
Competitors of Cambrooke Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cambrooke Therapeutics
When was Cambrooke Therapeutics founded?
Cambrooke Therapeutics was founded in 2000 and raised its 1st funding round 10 years after it was founded.
Where is Cambrooke Therapeutics located?
Cambrooke Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Cambrooke Therapeutics a funded company?
Cambrooke Therapeutics is a funded company, having raised a total of $17.28M across 5 funding rounds to date. The company's 1st funding round was a Grant of $64.4K, raised on Jun 11, 2010.
What does Cambrooke Therapeutics do?
Cambrooke Therapeutics was founded in 2000 in Boston, United States. Operations focus on the medical nutrition sector, where nutritional therapies are developed, manufactured, and commercialized for conditions including metabolic disorders, low-protein diets, and ketogenic needs. Products such as ready-to-drink formulas and powders are offered to meet patient requirements. Support services are extended to patients and healthcare professionals.
What products or services does Cambrooke Therapeutics offer?
Cambrooke Therapeutics offers Glytactin and KetoVie.
How many acquisitions has Cambrooke Therapeutics made?
Cambrooke Therapeutics has made 1 acquisition, including Nualtra.
Who are Cambrooke Therapeutics's investors?
Cambrooke Therapeutics has 3 investors. Key investors include Seventure Partners, Galen Partners, and Ajinomoto Health & Nutrition North America.